Radiolabelling of parenteral O/W emulsions by means of neutron activation

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 47, Issue 3, 1999, Pages 247-253

  Buszello, K ^a   Schnier, C ^b   Muller B W ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b INSTITUTE OF MATERIALS RESEARCH   (Germany)

Author keywords

Lanthanide; Neutron activation; O W Emulsion; Radiolabelling

Indexed keywords

EMULSIFYING AGENT; FATTY ACID DERIVATIVE; LANTHANIDE; SOLUTOL HS 15; WATER OIL CREAM;

ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; ISOTOPE LABELING; NEUTRON ACTIVATION ANALYSIS; NONHUMAN;

EMULSIONS; EUROPIUM; EXCIPIENTS; ISOTOPE LABELING; METALS, RARE EARTH; NEUTRONS; POLYETHYLENE GLYCOLS; SAMARIUM; STEARIC ACIDS; SURFACE-ACTIVE AGENTS;

EID: 0033041619     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(99)00002-8     Document Type: Article

References (11)

1. Digenis G.A., Sandfer E. Gamma scinigraphy and neutron activation techniques in the in vivo assessment of orally administered dosage forms. Crit. Rev. Ther. Drug Carrier Syst. 7:1993;309-345.
2. G.A. Digenis, Neutron activation methods for evaluation of pharmaceutical dosage forms, J. Congr. Int. Tech. Pharm. 5th 4 (1989) 80-89.
3. G.A. Digenis, A.F. Parr, M. Jay, Neutron Activation Methods for Evaluation of Pharmaceutical Dosage Forms, in: S.S. Davis, C.G. Wilson (Eds.), Drug Delivery to the Gastrintestinal Tract. Ellis Horwood, Chichester, 1989, pp. 111-119.
4. K.H. Leiser, Einfuhrung in die Kernchemie, third ed., VCH Verlagsgesellschaft mbH, Weinheim, 1991.
5. K. Buszello, B.W. Muller, The influence of alkali fatty acids on the properties and the stability of parenteral O/W emulsions modified with Solutol HS 15 (poster presentation), Third European Congress of Pharmaceutical Sciences, Edinburgh, 1996.
6. A. Gilmour, A. Jobling, S.M. Nelson, Aluminium trisoaps, J. Chem. Soc. (1956) 1972-1976.
7. Coupe A.J., Davis S.S., Wilding I.R. The preparation and characterization of samarium chelates as marker compounds for subsequent in-vivo dissolution studies. J. Pharm. Pharmacol. 42S:1990;126.
8. K. Buszello, B.W. Muller, Radiolabelling of parenteral O/W emulsions by means of neutron activatable samarium fatty acids, Proceedings of the third Controlled Release Society, Stockholm, 1997, pp. 811-812.
9. Parr A., Beihn R.M., Jay M. Radiolabelling of enteric coated tablet by (n, γ) radioactivation of erbium-170 for scintigraphic imaging. Int. J. Pharm. 32:1986;251-256.
10. M.B. Parnham, Toxicological safety of i.v. administered phospholipids and emulsions, Proceedings of CDC conference, third Expert Meeting on Controlled Drug Delivery, Berlin, 1997.
11. E. Seelmann, G. Pfennig, H. Münzel, H. Klewe-Nebenius, Karlsruher Nuklidkarte, 5. Auflags, Kernforschungszentrum Karlsruhe GmbH, Germany, 1981.